Key facts
- It has raised $80.0M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($80.0M) in Jan 2021.
- 2 institutional filers report fund marks on Vera Therapeutics across 7 filings.
- Vera Therapeutics has filed 1 Form D with the SEC, most recently Feb 2021 ($70.7M sold to 23 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Vera Therapeutics
Create free account
No card required
Funding rounds
1 roundsJan 2021Later Stage VC (Series C)$80.0M▮
About Vera Therapeutics
- Industry
- Drug Discovery
PA Mark — not yet priced
Vera Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Vera Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
2 filers · latest May 20262 SEC-registered funds reported 7 fair-value marks on Vera Therapeutics between Apr 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.